Search research articles
Contact Us
Filters
Showing results (171-180 of 201) with videos related to
Page
of 21
Sort By:
Neuroscience
|
August 29, 1998
Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use
J A Court, S Lloyd, N Thomas, et al.
Neurology
|
March 4, 1998
Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases
H Lamb, J Christie, A B Singleton, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1993
Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease
E K Perry, D Irving, J M Kerwin, et al.
The Ulster Medical Journal
|
July 19, 2005
Central line-related bacteraemia due to Tsukamurella tyrosinosolvens in a haematology patient
S Elshibly, J Doherty, J Xu, et al.
Pharmacogenetics
|
April 20, 1999
CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease
A Atkinson, A B Singleton, A Steward, et al.
Neurology
|
February 11, 2000
Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD
A M Gibson, A B Singleton, G Smith, et al.
Hippocampus
|
July 1, 1993
Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus
E K Perry, J A Court, M Johnson, et al.
Neuroscience Letters
|
August 19, 2019
Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice
P C Keane, P S Hanson, L Patterson, et al.
Neurology
|
July 26, 2000
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies
P F Chinnery, G A Taylor, N Howell, et al.
Novartis Foundation Symposium
|
March 31, 2001
Multiple substrates of late-onset dementia: implications for brain protection
R N Kalaria, C G Ballard, P G Ince, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 201) with videos related to
Sort By:
Page
of 21
Neuroscience
|
August 29, 1998
Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use
J A Court, S Lloyd, N Thomas, et al.
Neurology
|
March 4, 1998
Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases
H Lamb, J Christie, A B Singleton, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1993
Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease
E K Perry, D Irving, J M Kerwin, et al.
The Ulster Medical Journal
|
July 19, 2005
Central line-related bacteraemia due to Tsukamurella tyrosinosolvens in a haematology patient
S Elshibly, J Doherty, J Xu, et al.
Pharmacogenetics
|
April 20, 1999
CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease
A Atkinson, A B Singleton, A Steward, et al.
Neurology
|
February 11, 2000
Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD
A M Gibson, A B Singleton, G Smith, et al.
Hippocampus
|
July 1, 1993
Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus
E K Perry, J A Court, M Johnson, et al.
Neuroscience Letters
|
August 19, 2019
Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice
P C Keane, P S Hanson, L Patterson, et al.
Neurology
|
July 26, 2000
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies
P F Chinnery, G A Taylor, N Howell, et al.
Novartis Foundation Symposium
|
March 31, 2001
Multiple substrates of late-onset dementia: implications for brain protection
R N Kalaria, C G Ballard, P G Ince, et al.
Page
of 21